- Benefits and pitfalls of combination treatment with ACEI and AT blockers in terms of cardiovascular2010 | First Faculty of Medicine
- Sartans and ACE inhibitors in the treatment of hypertension2014 | Third Faculty of Medicine
- ACE inhibitors, sartans, or in the treatment of hypertension: unnecessary controversy?2014 | Third Faculty of Medicine
- AT1 blockers - comparability with ACE inhibitors2017 | First Faculty of Medicine
- ACE inhibitors - where we are and where we tend2002 | First Faculty of Medicine
- ACE inhibitors +12008 | First Faculty of Medicine
- ACE inhibitors and the heartPublication without faculty affiliation
- Angiotensin-converting enzyme inhibitors poisoning2003 | First Faculty of Medicine
- ACE inhibitors and mechanisms of their inhibiting of diabetes and cardiovascular diseases2004 | First Faculty of Medicine
- Treatment with ACE inhibitors and AT1-blockers during the COVID-19 pandemic2020 | Faculty of Medicine in Hradec Králové
- ACE - inhibitors and AT1R - antagonists are the first line medication for IgA nephropathy2008 | Second Faculty of Medicine
- From ACE blockade to angiotensin 2 blockade2004 | First Faculty of Medicine
- Diabetici 2. typu s akutním vzestupem koncentrace kreatininu v séru po zahájení léčby inhibitorem angiotenzin konvertujícího enzymu (ACEI) by měli v léčbě ACEI pokračovat2019 | First Faculty of Medicine
- ACE inhibitors2001 | Faculty of Medicine in Hradec Králové
- Inhibitory ACE versus sartany v léčbě primární hypertenze2016 | Third Faculty of Medicine
- Acetylsalicylid acid and ACE inhibitors in cardiac2002 | First Faculty of Medicine
- Amendment of the Czech Addenbrooke's Cognitive Examination (ACE-CZ)2011 | Third Faculty of Medicine, Central Library of Charles University
- Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cocotemporary cardiovascular pharmacotherapy2003 | First Faculty of Medicine
- Are differenes in angiotensin-converting-enzyme inhibitors clinicaly significant?2010 | Third Faculty of Medicine
- Kombinovaná léčba inhibitory ACE a AT1 blokátory a progrese renální insuficience2014 | First Faculty of Medicine
- The treatment of diabetic patient in 21st century: why it good to use ACE inhibitors2009 | First Faculty of Medicine
- Cardioprotective and renoprotective characteristics of ACE inhibitors. Imdidapril - ACE inhibitor of the new generation2004 | First Faculty of Medicine
- ACE inhibitors - pharmacologic overview2000 | Faculty of Medicine in Hradec Králové
- ACE inhibice - pár poznámek2003 | First Faculty of Medicine
- Renoprotective characteristics of ACE inhibitors2004 | First Faculty of Medicine
- Whats new in the indication of ACE-inhibitors?2000 | First Faculty of Medicine
- Dávkování inhibitorů ACE u hypertenze2016 | First Faculty of Medicine
- Telemedicine assessments by remote versions of ALBA, POBAV and ACE-III tests2022 | Third Faculty of Medicine, Faculty of Physical Education and Sport
- No evidence for linkage between the hereditary angiooedema clinical phenotype and the BDKRl,BDKR2, ACE or MBL2 gene.2011 | First Faculty of Medicine